Pheast Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Pheast Therapeutics

Access the complete profile.

Pheast Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	621112 Physicians, Mental Health Specialists
Address	3160 Porter Drive, Ste 210 Palo Alto, CA 94304

Note: Revenues for privately held companies are statistical evaluations.


Pheast Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Pheast Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Pheast Therapeutics is classified as operating in the Physicians, Mental Health Specialists industry, NAICS Code 621112.

Pheast Therapeutics Annual Revenue and Growth Rate

Pheast Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Pheast Therapeutics's revenues are gauged from an analysis of company filings.

Pheast Therapeutics's Income Statement (based on Industry Averages)

Pheast Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Pheast Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
October 28, 2022	7	34%	$75 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Pheast Therapeutics is developing and marketing. Pheast Therapeutics doesn't have any recent trademark applications, indicating Pheast Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
PHEAST THERAPEUTICS pharmaceutical preparations for the treatment of cancer	03/04/2022

See all trademarks and details in the Full Report.

Market Share of Pheast Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Pheast Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
MAYO CLINIC AMBULANCE	Rochester, MN	100
SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP	Pasadena, CA	49
WEST VIRGINIA UNIVERSITY HOSPITALS	Morgantown, WV	39
PERMANENTE MEDICAL GROUP	Oakland, CA	37
MARSHFIELD CLINIC	Marshfield, WI	13
HEALTHCARE PARTNERS INSTITUTE FOR APPLIED RESEARCH & EDUCATION	El Segundo, CA	10
MHM SERVICES	Sterling, VA	7
MAGELLAN HEALTHCARE	Columbia, MD	5
ALTERNATIVE BEHAVIOR STRATEGIES	Salt Lake City, UT	5

Nearby Competitors

These companies are similar in business line and location to Pheast Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PACKARD CHILDREN'S HEALTH ALLIANCE	Palo Alto, CA	100
PACKARD MEDICAL GROUP	Palo Alto, CA	45
CALIFORNIA EAR INSTITUTE	East Palo Alto, CA	8
PALO ALTO PATHOLOGY	Palo Alto, CA	6
L&P AESTHETICS MEDICAL	Palo Alto, CA	6
PENINSULA BEHAVIORAL HEALTH	Palo Alto, CA	6

Future Competition: Pheast Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Pheast Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)